Previous Close | 1.0000 |
Open | 3.5000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 75.00 |
Expire Date | 2024-05-17 |
Day's Range | 1.0000 - 3.5000 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Kodiak (KOD) reports better-than-expected first-quarter 2024 results and provides updates regarding its pipeline development plans.
Vanda's (VNDA) tradipitant appears effective in preventing vomiting associated with motion sickness in a second phase III study. Stock rises on the news.
On May 14, 2024, Matthew Korenberg, President & Chief Operating Officer of Ligand Pharmaceuticals Inc (NASDAQ:LGND), executed a sale of 17,598 shares of the company.